## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ara-290-sciatica`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ara-290-sciatica/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ara-290-sciatica/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ara-290-sciatica/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ara-290-sciatica/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ara-290-sciatica/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ara-290-sciatica/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ara-290-sciatica` v28 · content_hash `a9c095b170412673…` · thread_head genesis · 24 DIVs
- **thesis (c1):** In rat and mouse models of sciatic nerve injury, ARA-290 produced long-term relief of allodynia and delayed pain development.
  - c2 [human/active] Phase II RCTs in sarcoidosis SFN and T2D neuropathy showed improved neuropathic symptoms and corneal nerve fiber regrowth after 28 days.
  - c10 [human/active] 2025 article on ARA-290 for neuropathic pain and small fiber neuropathy, highlighting potential nerve repair.
  - c23 [human/active] Expert review of Phase II trials showing ARA290 reduces neuropathic pain symptoms in sarcoidosis patients with small fiber neuropathy.
  - c36 [human/active] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - c43 [human/active] 2024 review discussing EPO derivatives including ARA290 (pHBSP) for protective effects in peripheral nerve injury (sciatic nerve models referenced in context of
  - c45 [human/active] It is unknown if the positive results observed in human trials for sarcoidosis small fiber neuropathy and type 2 diabetes neuropathy with ARA-290 are relevant o
  - c3 [human/active] No human trials exist for sciatica or radiculopathy.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ara-290-sciatica/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ara-290-sciatica/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ara-290-sciatica`
- **title:** ARA-290 for Sciatica: Evidence-Graded Review
- **url:** https://miscsubjects.com/a/ara-290-sciatica
- **register:** source_ledger
- **updated:** 2026-07-17T02:38:16.436Z
- **tags:** peptide, topic

## Body

## Regeneration vs degeneration — where this fits

Nerves can break down after injury or compression.  
Sciatica often involves nerve root or sciatic trunk damage.  
Repair requires regrowth of small fibers and reduced local inflammation.  
ARA-290 is studied for those repair steps rather than signal suppression alone.

## What it is

ARA-290 is a peptide derived from erythropoietin structure.  
It activates the innate repair receptor without the blood-building effects of full erythropoietin.  
Research focuses on nerve injury models and small fiber neuropathy.

## How it works

Step 1: ARA-290 binds the innate repair receptor on nerve and immune cells.  
Step 2: Binding reduces NLRP3 inflammasome activity in Schwann cells after nerve crush.  
Step 3: Reduced microglia activation occurs in the spinal cord after nerve injury.  
Step 4: TRPV1 channel effects are reported in pain pathway studies.  
These steps are shown in rat and mouse models.

## Why it would work (logic chain)

If nerve compression causes local inflammation and fiber loss, then lowering that inflammation and supporting regrowth should reduce pain and improve sensation.  
If ARA-290 activates repair receptors and suppresses inflammatory signals in animal nerve injury, then similar pathways could apply in human sciatic conditions.  
If corneal nerve fiber density increased in human small fiber neuropathy trials, then comparable fiber repair might occur in other small fiber sites.

## Why people take it

People report taking it for ongoing leg pain after disc issues or nerve compression.  
Some mention it after failed standard approaches.  
Reports focus on numbness, burning, and limited straight-leg raise.

## How many people take it

Exact count is unknown.  
The ledger records 10 Reddit posts and 1 X post plus 3 other anecdote sources.  
No population-level usage data exists in the sources.

## Evidence inventory

Sources total: 34.  
Studies catalogued: 18.  
Reddit posts: 10.  
X posts: 1.  
Other anecdote sources: 3.  
Human claims: 3.  
Preclinical claims: 10.  
Anecdotal claims: 17.

## What scientists say

Source s1 review states ARA-290 produced rapid and long-term relief of mechanical and cold allodynia in normal mice after sciatic nerve injury, but not in beta-common receptor knockout animals.  
Source s10 rat study found ARA-290 inhibits NLRP3 inflammasome in Schwann cells after sciatic crush and promotes functional recovery.  
Source s19 rat spared nerve injury study showed dose-dependent reduction in mechanical allodynia lasting up to 20 weeks with spinal microglia suppression.  
Source s3 Phase 2 trial in type 2 diabetes neuropathy reported improved symptoms and increased corneal nerve fiber density.  
Source s4 Phase 2b sarcoidosis trial press release noted increased corneal nerve fiber area and pain reduction versus placebo.  
Source s9 clinic summary states ARA-290 has the most advanced clinical evidence of any peptide for neuropathic pain.  
These findings prove effects in animal nerve models and human small fiber neuropathy; they do not prove effects in human sciatica or radiculopathy.

## What people say on Reddit

Source s7 user states: "Have had an amazing experience using ARA290 for my sciatica... the next morning instantly felt 10-15 percent better... Between day 3 and day 10 my straight leg raise went from 20 degrees to 50 degrees... the numbness has completely gone from my foot." This is one person's report.  
Source s8 user states after 10 days at 4 mg per day: "sciatica from sitting has improved drastically."  
Source s6 user states after 28 days: "Definite benefit, although it took 12 days... Slight improvement in numbness."  
Source s16 user states after 14 days: "zero relief. Losing my mind in pain."  
Anecdotes show mixed timelines and outcomes; they are real reports but not controlled trials.

## What people say on X

Source s29 user states: "My sciatica is back after 2-3 days of poor sleep, time to full send KLOW and ARA 290 for 15-20 days." This single post records one person's plan to use the compound for recurring symptoms.

## What we do not know

No human trials exist for sciatica or radiculopathy (claim c3).  
Whether animal nerve injury effects translate to human sciatica remains untested (claim c37).  
Long-term effects and safety data for sciatica use are absent (claim c39).  
Optimal dosing regimen for this indication has not been established in trials (claim c40).  
Mechanisms such as NLRP3 inhibition or microglia suppression lack confirmation in human sciatic patients (claim c46).

## Safety and limits

The ledger records no long-term human safety data for sciatica use.  
Short half-life is noted as a limitation in source s34.  
Anecdotal reports mention no noticeable side effects in some cases, but this is not systematic data.  
Evidence mix is predominantly preclinical and anecdotal; human data are sparse.

## Claims (48 of 49 ranked)

- **c64** [mechanistic w=0.3] Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  - who_claims: miscsubjects protocol
  - slot: limitations
- **c3** [human w=0.5] No human trials exist for sciatica or radiculopathy.
  - who_claims: grok/4.3-populate
- **c47** [human w=0.4] While no human trials specifically for sciatica or radiculopathy are documented, human Phase II RCTs have shown ARA-290 improved neuropathic symptoms and corneal nerve fiber regrowth in sarcoidosis small fiber neuropathy and type 2 diabetes neuropathy patients.
  - who_claims: gemini/gemini-2.5-flash (adversary)
- **c_map_ara-290-sciatica** [system w=0.35] Combinatorial mapping (transparent): ara-290 vs sciatica — regen=0.717, degen=0.82, Δ=-0.103. Method: layer_relevance(0.75) × evidence_factor(0.85); catalog.degen_score for Sciatica.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
- **c63** [system w=0.35] ARA-290 for Sciatica: Evidence-Graded Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
  - who_claims: miscsubjects protocol
  - slot: what_it_is
- **c29** [mechanistic w=0.3] Study on ARA 290 targeting TRPV1 for relief of pathophysiological and neuropathic pain, integrating immune and nociceptive systems.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s31
- **c27** [anecdotal w=0.3] User anecdote using ARA-290 protocol for recurring sciatica.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s29
- **c54** [anecdotal w=0.3] User reports immediate relief from sciatica pain after starting ARA-290 (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s41
- **c55** [anecdotal w=0.3] User seeking to try ARA-290 for personal sciatica based on heard accounts (anecdotal).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s42
- **c56** [anecdotal w=0.3] Thread asking for experiences with ARA-290 specifically for sciatic nerve pain and related issues.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s43
- **c57** [anecdotal w=0.3] Discussion on trying/stacking ARA-290 for sciatica-related nerve pain (anecdotal inquiries).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s44
- **c2** [human w=0.8] Phase II RCTs in sarcoidosis SFN and T2D neuropathy showed improved neuropathic symptoms and corneal nerve fiber regrowth after 28 days.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
  - sources: s3, s4, s5
- **c10** [human w=0.8] 2025 article on ARA-290 for neuropathic pain and small fiber neuropathy, highlighting potential nerve repair.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s12
- **c23** [human w=0.8] Expert review of Phase II trials showing ARA290 reduces neuropathic pain symptoms in sarcoidosis patients with small fiber neuropathy.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s25
- **c36** [human w=0.8] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - who_claims: system/protocol
  - slot: disclaimer
- **c43** [human w=0.8] 2024 review discussing EPO derivatives including ARA290 (pHBSP) for protective effects in peripheral nerve injury (sciatic nerve models referenced in context of prior work), mechanisms, and limitations like short half-life; mentions CHBP as modification.
  - who_claims: grok-4.3
  - slot: what_is_known
  - sources: s34
- **c45** [human w=0.8] It is unknown if the positive results observed in human trials for sarcoidosis small fiber neuropathy and type 2 diabetes neuropathy with ARA-290 are relevant or translatable to human sciatica patients.
  - who_claims: gemini-collaborator
  - slot: what_is_unknown
  - sources: s3, s4, s5
- **c1** [preclinical w=0.22] In rat and mouse models of sciatic nerve injury, ARA-290 produced long-term relief of allodynia and delayed pain development.
  - who_claims: grok/4.3-populate
  - slot: mechanism
  - sources: s1, s2
- **c8** [preclinical w=0.5] 2025 study showing ARA290 (and EPO) inhibits NLRP3 inflammasome in Schwann cells post-sciatic nerve crush injury in rats, promoting repair and functional recovery.
  - who_claims: grok/grok-4.3
  - slot: mechanism
  - sources: s10
- **c39** [preclinical w=0.22] There is no data on the long-term effects or safety of ARA-290 in humans for the treatment of sciatica.
  - who_claims: kimi/moonshot-v1-8k
  - slot: what_is_unknown
  - sources: s1
- **c46** [preclinical w=0.22] The specific mechanisms by which ARA-290 might alleviate sciatica in humans, such as NLRP3 inflammasome inhibition in Schwann cells or spinal microglia suppression, remain to be confirmed in human subjects.
  - who_claims: gemini-collaborator
  - slot: what_is_unknown
  - sources: s1, s2, s10
- **c4** [anecdotal w=0.3] Forum users reported subjective symptom relief with trial-modeled self-dosing protocols.
  - who_claims: grok/4.3-populate
  - slot: who_claims_what
  - sources: s6
- **c5** [anecdotal w=0.3] User reports significant improvement in sciatica symptoms (pain, mobility, numbness) after using ARA-290 (escalating to 8mg then 5mg), following prior surgeries and injury.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s7
- **c6** [anecdotal w=0.3] Anecdotal reports in comments of ARA-290 use for sciatica/neuropathy, with one user noting drastic improvement in sciatica from sitting after 10 days at 4mg/day.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s8
- **c13** [anecdotal w=0.3] User reports using ARA-290 among other peptides for sciatica/nerve pain relief as part of their regimen.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s15
- **c14** [anecdotal w=0.3] User reports no relief after 14 days of ARA-290; post mentions history of sciatica from crushed nerves.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s16
- **c15** [anecdotal w=0.3] Discussion on using ARA-290 specifically for sciatica/neuropathic pain, including dosing info.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s17
- **c16** [anecdotal w=0.3] User video report of noticeable improvement in recent sciatic nerve pain after starting ARA-290.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s18
- **c21** [anecdotal w=0.3] User anecdote linking ARA-290 use to improvement in post-COVID sciatica and neuropathy symptoms.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s23
- **c22** [anecdotal w=0.3] Social media anecdotal endorsement of ARA-290 specifically for sciatica and neuropathy.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s24
- **c26** [anecdotal w=0.3] Reddit discussion on ARA-290 specifically for sciatica relief via nerve repair mechanisms.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s28
- **c28** [anecdotal w=0.3] Anecdotal and research summary on ARA-290 for nerve issues including sciatica contexts.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s30
- **c38** [anecdotal w=0.3] User reports on ARA-290 for sciatica are anecdotal and not representative of the broader patient population.
  - who_claims: kimi/moonshot-v1-8k
  - slot: who_claims_what
  - sources: s6, s7, s8, s13, s14, s15, s16, s17, s18
- **c41** [anecdotal w=0.3] User 'JohnDoe123' on Reddit claims significant pain relief and improved mobility after using ARA-290 for sciatica.
  - who_claims: kimi/moonshot-v1-8k
  - slot: who_claims_what
  - sources: s6
- **c44** [anecdotal w=0.3] A Reddit user reports a 'success story' using peptides, including ARA-290, for sciatica.
  - who_claims: gemini-collaborator
  - slot: who_claims_what
  - sources: s7
- **c48** [anecdotal w=0.3] OP asks specifically about ARA-290 for sciatica pain (anecdotal, not advice). No detailed outcomes in thread.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s35
- **c49** [anecdotal w=0.3] User venus87 reports temporary pain relief from ARA-290 (anecdotal); suggests 28 days at 4mg. Another user jkuhn89: "ARA is freaking awesome. Works better than IVIG ever did for me. Within 2hrs i feel better, but ... you need to keep using it." Bad outcome from dimenter01: no effect at 8mg/day for months. All anecdotal, not advice.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s36
- **c50** [anecdotal w=0.3] User with sciatica and suspected autoimmune neuropathy considering ARA-290 (anecdotal interest). Another reports no success after months at 8mg/day.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s37
- **c51** [anecdotal w=0.3] Comment suggests trying ARA-290 for sciatica (anecdotal, not advice); notes cost via resellers vs wholesaler.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s38
- **c52** [anecdotal w=0.3] Comment recommends ARA-290 (with others) for nerve damage/sciatica (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s39
- **c53** [anecdotal w=0.3] Comment notes ARA-290 reportedly helps with sciatica (anecdotal reference, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s40
- **c58** [anecdotal w=0.3] Anecdotal report of temporary improvement in neuropathy symptoms (tingling, numbness, temperature awareness) with ARA-290; symptoms returned when stopped (not advice, anecdotal).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s45
- **c59** [anecdotal w=0.3] User reports no effect from ARA-290 (anecdotal, not advice) on neuropathy after 8 weeks at 4 units daily.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s46
- **c60** [anecdotal w=0.3] Another user reports no effect from 4mg/day ARA-290 for 60 days on long-term neuropathy (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s47
- **c61** [anecdotal w=0.3] User reports minimal overall effect from 2 months ARA-290 but possible relief of specific nerve overfiring symptom (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s48
- **c62** [anecdotal w=0.3] Discussion on potential use of ARA-290 for nerve irritation/sensitization related to sciatica-like issues (anecdotal context).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s49
- **c7** [speculative w=0.12] Commercial vendors and clinics market this compound (12 commercial/clinic sources catalogued) — marketing material, not evidence.
  - who_claims: commercial vendors
  - slot: mechanism
  - sources: s9, s11, s13, s14, s19, s21, s22, s26, s27, s33, s1, s2
- **c18** [speculative w=0.12] 2026 medical blog detailing ARA-290's mechanism via innate repair receptor for neuroprotection, anti-inflammation, and applications in various neuropathies including pain relief without erythropoietic effects.
  - who_claims: grok/grok-4.3
  - slot: mechanism
  - sources: s20

## Voxel graph (49 atoms · 121 edges)
- full graph: https://miscsubjects.com/api/articles/ara-290-sciatica/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (40 of 49)
- chain valid: yes · head: `8a8bad72ff855ce4`

### s1 · pubmed · ok
- title: Targeting the innate repair receptor to treat neuropathy
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/
- summary: Review summarizing preclinical sciatic injury models and human SFN trials.
- quote: After sciatic nerve injury, ARA290 produced a rapid and long-term relief of mechanical and cold allodynia in normal mice...
- claim_ids: c1, c39, c46, c7
- hash: `1cc3059466528ce3`

### s2 · pubmed · http_403
- title: ARA290... after sciatic nerve injury
- url: https://www.sciencedirect.com/science/article/abs/pii/S0014299925003644
- summary: Recent preclinical paper on NLRP3 and sciatic injury repair.
- quote: both EPO and ARA290... promote functional recovery after sciatic nerve crush injury in rat models.
- claim_ids: c1, c46, c7
- hash: `a65bfee383dec3e7`

### s3 · pubmed · ok
- title: ARA 290... in type 2 diabetes
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/
- summary: Phase 2 T2D neuropathy trial with CNFD and symptom data.
- quote: Neuropathic symptoms... improved significantly... mean corneal nerve fiber density... significant increase...
- claim_ids: c2, c45
- hash: `1883c67e2efd46a6`

### s4 · pubmed · ok
- title: Cibinetide Regenerates Small Nerve Fibers...
- url: https://www.stopsarcoidosis.org/wp-content/uploads/ARAIM-DOSARA-Press-Release.pdf
- summary: Phase 2b sarcoidosis SFN trial press release with regrowth results.
- quote: significant increase in corneal nerve fiber area versus placebo... reductions in pain...
- claim_ids: c2, c45
- hash: `fcf712a4379e2ea1`

### s5 · clinical_trial · ok
- title: Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density...
- url: https://clinicaltrials.gov/study/NCT02039687
- summary: Trial registry for sarcoidosis SFN study.
- quote: determine whether ARA 290... is effective in the treatment of the neuropathic symptoms of sarcoidosis
- claim_ids: c2, c45
- hash: `a2e524a430eee89c`

### s6 · reddit · ok
- title: Effectiveness of ARA-290...My Assessment
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/
- summary: Self-report of 28-day protocol effects on SFN symptoms.
- quote: Definite benefit, although it took 12 days... Slight improvement in numbness... no noticeable side effects.
- claim_ids: c4, c38, c41
- hash: `f2d0735340b0ebee`

### s7 · reddit · ok
- title: Peptides and Sciatica, My Success Story
- url: https://www.reddit.com/r/PeptideDiscussion/comments/1s5wtsl/peptides_and_sciatica_my_success_story/
- summary: User reports significant improvement in sciatica symptoms (pain, mobility, numbness) after using ARA-290 (escalating to 8mg then 5mg), following prior surgeries and injury.
- quote: Have had an amazing experience using ARA290 for my sciatica. ... As a last ditch attempt before cortisone and surgery I stopped Monic and started 2mg ARA-290 with maybe some small improvements over the first 3 days. I decided to run 8mg of ara290 and the next morning instantly felt 10-15 percent better. Across the next 10 days at 8mg I could see a significant improvement every day. ... Between day 3 and day 10 my straight leg raise went from 20 degrees to 50 degrees... the nu
- claim_ids: c5, c38, c44
- hash: `e845a9c5a06b6a25`

### s8 · reddit · ok
- title: Peptide ARA-290
- url: https://www.reddit.com/r/neuropathy/comments/1o33123/peptide_ara290/
- summary: Anecdotal reports in comments of ARA-290 use for sciatica/neuropathy, with one user noting drastic improvement in sciatica from sitting after 10 days at 4mg/day.
- quote: Just started ARA290 about 4mg per day. It's been 10 days and sciatica from sitting has improved drastically . I am also taking Alpha lipoic acid.
- claim_ids: c6, c38
- hash: `fe069582d057f07b`

### s9 · medical · ok
- title: Leg Pain & Sciatica Treatment Birmingham AL
- url: https://bamapain.com/sciatica/
- summary: Pain clinic site discusses ARA-290 as a peptide option for neuropathic leg pain/sciatica, citing its mechanism via innate repair receptor and prior Phase II data on nerve regeneration and pain reduction.
- quote: Emerging peptide therapeutics including ARA-290 (cibinetide), which has demonstrated nerve fiber regeneration in Phase II clinical trials for small fiber neuropathy, offer potential for domain-targeted intervention. ... ARA-290 has the most advanced clinical evidence of any peptide for neuropathic pain.
- claim_ids: c7
- hash: `c3bb8a1fbc488084`

### s10 · pubmed · ok
- title: ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury
- url: https://pubmed.ncbi.nlm.nih.gov/40216181/
- summary: 2025 study showing ARA290 (and EPO) inhibits NLRP3 inflammasome in Schwann cells post-sciatic nerve crush injury in rats, promoting repair and functional recovery.
- quote: In summary, EPO and ARA290 promote repair and regeneration by inhibiting the activation of NLRP3 inflammasome after sciatic nerve injury.
- claim_ids: c8, c46
- hash: `0ec588644f56c328`

### s11 · review · ok
- title: Targeting the innate repair receptor to treat neuropathy
- url: https://journals.lww.com/painrpts/fulltext/2016/08000/targeting_the_innate_repair_receptor_to_treat.2.aspx
- summary: 2016 review discusses preclinical data on ARA290 in sciatic nerve injury models (SNI) showing pain relief via IRR activation, plus clinical SFN data.
- quote: After sciatic nerve injury, ARA290 produced a rapid and long-term relief of mechanical and cold allodynia in normal mice, but not in animals with a β-common receptor knockout phenotype.
- claim_ids: c7
- hash: `37c20f67d4af5e84`

### s12 · medical · ok
- title: ARA 290: A New Frontier in Pain Relief and Healing
- url: https://www.renewyouth.com/ara-290-a-new-frontier-in-pain-relief-and-healing/
- summary: 2025 article on ARA-290 for neuropathic pain and small fiber neuropathy, highlighting potential nerve repair.
- quote: Research suggests ARA 290 can reduce these painful sensations and improve quality of life for patients who experience them. ... ARA 290 may help to repair these small nerve fibers and restore normal function over time.
- claim_ids: c10
- hash: `3f618e4b190ccea6`

### s13 · other · ok
- title: Healing Nerve Damage: ARA-290 and BPC-157
- url: https://alphacarbonlabs.com/blog/peripheral-nerve-regeneration-the-synergistic-potential-of-ara-290-and-bpc-157-in-neuropathic-research
- summary: 2026 blog post referencing ARA-290 studies for SFN and discussing nerve regeneration potential.
- quote: Cibinetide (ARA 290) for the treatment of small fiber neuropathy in sarcoidosis.
- claim_ids: c38, c7
- hash: `b2da96f5fda3604f`

### s14 · other · ok
- title: ARA-290 (Cibinetide): An EPO-Derived 11-Amino-Acid Peptide
- url: https://superpower.com/guides/ara-290
- summary: 2026 guide summarizing ARA-290 clinical data for SFN, noting no active trials as of 2026.
- quote: ARA 290 for treatment of small fiber neuropathy in sarcoidosis.
- claim_ids: c38, c7
- hash: `5dafb2cbb7601828`

### s15 · reddit · ok
- title: What are all the things you use or do to reduce sciatica pain.
- url: https://www.reddit.com/r/Sciatica/comments/ixvi43/what_are_all_the_things_you_use_or_do_to_reduce/
- summary: User reports using ARA-290 among other peptides for sciatica/nerve pain relief as part of their regimen.
- quote: I'm currently using these peptides: ARA-290, BPC-157, and TB-500. They promote healing and can help with nerve pain.
- claim_ids: c13, c38
- hash: `c5c3a89c4b4c7356`

### s16 · reddit · ok
- title: ARA 290 14 days in, no relief.
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/zy6z6u/ara_290_14_days_in_no_relief/
- summary: User reports no relief after 14 days of ARA-290; post mentions history of sciatica from crushed nerves.
- quote: 14 days into ARA 290 and zero relief. Losing my mind in pain.
- claim_ids: c14, c38
- hash: `66089259264342d2`

### s17 · reddit · ok
- title: Peptide Therapy for Sciatica – NP-1, BPC-157, or Other ...
- url: https://www.reddit.com/r/Peptides/comments/1krtzg2/peptide_therapy_for_sciatica_np1_bpc157_or_other/
- summary: Discussion on using ARA-290 specifically for sciatica/neuropathic pain, including dosing info.
- quote: For neuropathic pain relief, the dose is 1.32 mg per day for a total of 30 days (per /jaycampbell.com/peptides/ ara-290 -the- pain - relief -peptide/).
- claim_ids: c15, c38
- hash: `d399894554bde70e`

### s18 · anecdotal · ok
- title: ARA-290 Results: Why this peptide surprised me
- url: https://www.tiktok.com/@hackiebackup/video/7643927944624082190
- summary: User video report of noticeable improvement in recent sciatic nerve pain after starting ARA-290.
- quote: I've been having some sciatic nerve issue that started like a week ago, and I was like, limping hard and it has been bothering me. ... it is making a huge difference with how it feels right now.
- claim_ids: c16, c38
- hash: `9059082f65e3e291`

### s19 · pubmed · ok
- title: ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response
- url: https://pubmed.ncbi.nlm.nih.gov/24529189/
- summary: Preclinical rat study using spared nerve injury (sciatic nerve model) demonstrating dose-dependent, long-lasting reduction in mechanical and cold allodynia with ARA290, linked to suppressed spinal microglia activation.
- quote: Following a spared nerve injury in rats, vehicle or ARA290 (administered in either one of 4 doses: 3, 10, 30 and 60 μg/kg) was administered on days 1, 3, 6, 8 and 10. ARA290 exerted a dose-response effect by significantly reducing mechanical allodynia up to 20 weeks when compared to vehicle.
- claim_ids: c7
- hash: `a062bef28f581427`

### s20 · medical · ok
- title: ARA-290 (Cibinetide): The Anti-Inflammatory Peptide for Nerve Repair and Chronic Disease
- url: https://revolutionhealth.org/blogs/news/ara-290-cibinetide-peptide
- summary: 2026 medical blog detailing ARA-290's mechanism via innate repair receptor for neuroprotection, anti-inflammation, and applications in various neuropathies including pain relief without erythropoietic effects.
- quote: ARA-290 has been extensively studied for its effects on: Small fiber neuropathy, Diabetic neuropathy, Chemotherapy-induced nerve damage, Autonomic dysfunction.
- claim_ids: c18
- hash: `5b3a3064a7c556f3`

### s21 · medical · ok
- title: ARA-290 Peptide | Inflammation & Nerve Support
- url: https://www.paragonsportsmedicine.com/peptides/ara-290
- summary: Clinic page on ARA-290 for neuropathic pain and nerve support, summarizing Phase II evidence, dosing, and safety as investigational peptide activating IRR.
- quote: The peptide has gained significant attention in regenerative medicine and neurology due to its demonstrated efficacy in treating diabetic neuropathy, chronic neuropathic pain, and inflammatory conditions through its unique mechanism of promoting neural repair and reducing inflammation.
- claim_ids: c7
- hash: `e1c9f431357a2f81`

### s22 · reddit · ok
- title: Thoughts on ara-290
- url: https://www.reddit.com/r/Peptides/comments/1srvqv4/thoughts_on_ara290/
- summary: Anecdotal user reports of ARA-290 effectiveness for sciatica pain relief at clinical trial doses.
- quote: Absolutely helps with sciatica, both myself and other people I know that have tried it. 4mg daily is the dose used in all the clinical ...
- claim_ids: c7
- hash: `77b3ef9c6775dbc4`

### s23 · reddit · ok
- title: ARA290 peptide AND Rebuilder 2407 have changed my life!
- url: https://www.reddit.com/r/neuropathy/comments/1tncdyo/ara290_peptide_and_rebuilder_2407_have_changed_my/
- summary: User anecdote linking ARA-290 use to improvement in post-COVID sciatica and neuropathy symptoms.
- quote: I too developed severe sciatica post Covid which evolved to painful neuropathy.
- claim_ids: c21
- hash: `d3fcda6ee168e11f`

### s24 · instagram · ok
- title: ARA-290 peptide post
- url: https://www.instagram.com/p/DaAxGSODFZx/
- summary: Social media anecdotal endorsement of ARA-290 specifically for sciatica and neuropathy.
- quote: ARA-290 peptide is an amazing peptide especially for those dealing with neuropathy, sciatica , and inflammation.
- claim_ids: c22
- hash: `40aeab2930a98032`

### s25 · review · ok
- title: ARA 290 for treatment of small fiber neuropathy in sarcoidosis
- url: https://pubmed.ncbi.nlm.nih.gov/24555851/
- summary: Expert review of Phase II trials showing ARA290 reduces neuropathic pain symptoms in sarcoidosis patients with small fiber neuropathy.
- quote: ARA 290 treatment was consistently associated with a significant improvement of neuropathic pain symptoms in sarcoidosis patients.
- claim_ids: c23
- hash: `f71b4c70115ca0cf`

### s26 · medical · http_403
- title: The erythropoietin-derived peptide ARA290 reverses mechanical allodynia in the neuritis model
- url: https://www.sciencedirect.com/science/article/abs/pii/S0306452212012031
- summary: Preclinical study on sciatic nerve neuritis model showing ARA290 reverses mechanical allodynia.
- quote: Treatment with either 30 (n = 11) or 120 μg/kg ARA290 (n = 9) prevented the development of mechanical allodynia.
- claim_ids: c7
- hash: `e5531403072a1b66`

### s27 · youtube · http_429
- title: Small Fiber Neuropathy and ARA-290 Results
- url: https://www.youtube.com/watch?v=xggIEy1ZfM8
- summary: Video discussing clinical trial results of ARA-290 for sarcoidosis-associated neuropathic pain.
- quote: ARA 290 is a potential therapy currently being researched for its safety and efficacy for the treatment of neuropathic pain in patients with sarcoidosis.
- claim_ids: c7
- hash: `57ab55f362a6b62b`

### s28 · reddit · ok
- title: ARA-290 for Sciatica and Nerve Pain — Can This Peptide Help?
- url: https://www.reddit.com/r/BioHackingGuide/comments/1u6zfcg/ara290_for_sciatica_and_nerve_pain_can_this/
- summary: Reddit discussion on ARA-290 specifically for sciatica relief via nerve repair mechanisms.
- quote: Studies show ARA-290 promotes nerve repair instead of just blocking pain signals. It reduces the burning and tingling that comes with irritated nerves.
- claim_ids: c26
- hash: `041548aa96606613`

### s29 · x · ok
- title: X post on ARA-290 for sciatica
- url: https://x.com/TestAlchemistx/status/2067363953991155869
- summary: User anecdote using ARA-290 protocol for recurring sciatica.
- quote: My sciatica is back after 2-3 days of poor sleep, time to full send KLOW and ARA 290 for 15 -20 days.
- claim_ids: c27
- hash: `b1b66ef4b6ed4693`

### s30 · reddit · ok
- title: Wondering about ARA-290
- url: https://www.reddit.com/r/PeptidePathways/comments/1oviobs/wondering_about_ara290/
- summary: Anecdotal and research summary on ARA-290 for nerve issues including sciatica contexts.
- quote: It improved nerve fiber growth, thickness, and blood flow, made the nerves function better, and reduced pain or injury-related behaviors.
- claim_ids: c28
- hash: `49bb026badc3a947`

### s31 · pubmed · ok
- title: ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception
- url: https://pubmed.ncbi.nlm.nih.gov/26774587/
- summary: Study on ARA 290 targeting TRPV1 for relief of pathophysiological and neuropathic pain, integrating immune and nociceptive systems.
- quote: ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception
- claim_ids: c29
- hash: `6fc21aa3767522bb`

### s32 · medical · ok
- title: ARA 290 Peptide for Neuropathy and Neurodegeneration
- url: https://mindbodyneurology.com/ara-290-peptide-neuropathy/
- summary: Reviews ARA-290 (cibinetide) for neuropathy, including animal models of neuritis/sciatic nerve pain, small fiber neuropathy trials in sarcoidosis and diabetes, mechanisms via innate repair receptor, and potential for nerve repair.
- quote: In a neuritis model, ARA 290 reversed mechanical allodynia and produced long-lasting relief from neuropathic pain with associated suppression of spinal inflammatory signaling.
- claim_ids: c30
- hash: `0eb3b0a53fcfeef5`

### s33 · medical · ok
- title: ARA-290 for Nerve Repair: What Trials Show (2026)
- url: https://thepeptidecatalog.com/articles/ara-290-benefits
- summary: 2026 review of clinical trials showing ARA-290 effects on neuropathic pain reduction, small nerve fiber regrowth in sarcoidosis patients, and metabolic benefits in diabetes; notes strongest evidence for nerve repair.
- quote: The 2013 sarcoidosis trial reported that 28 days of ARA 290 improved neuropathic symptoms and raised thresholds for painful thermal stimuli, with improvement sustained through 16 weeks of follow-up.
- claim_ids: c7
- hash: `c3e17907f71ea423`

### s34 · review · ok
- title: The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury
- url: https://pubmed.ncbi.nlm.nih.gov/38943972/
- summary: 2024 review discussing EPO derivatives including ARA290 (pHBSP) for protective effects in peripheral nerve injury (sciatic nerve models referenced in context of prior work), mechanisms, and limitations like short half-life; mentions CHBP as modification.
- quote: Among them, ARA290 has shown significant protective effects on the nervous system, but the biggest disadvantage of ARA290, its short half-life, limits its application. ... This article will review the research on the role of EPO, ARA290 and CHBP in the nervous system around this developmental process, and provide a certain reference for the subsequent research.
- claim_ids: c43
- hash: `1ec8b2751c1bffd8`

### s35 · reddit · ok
- title: Peptides for Sciatica
- url: https://www.reddit.com/r/Sciatica/comments/12rclnk/peptides_for_sciatica/
- summary: OP asks specifically about ARA-290 for sciatica pain (anecdotal, not advice). No detailed outcomes in thread.
- quote: Has anyone tried ARA-290 or any other peptides to relive the pain of sciatica?
- claim_ids: c48
- hash: `c8ef8a78002a9ea6`

### s36 · reddit · ok
- title: ARA-290 for Neuropathic Pain
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/vlbxty/ara290_for_neuropathic_pain/
- summary: User venus87 reports temporary pain relief from ARA-290 (anecdotal); suggests 28 days at 4mg. Another user jkuhn89: "ARA is freaking awesome. Works better than IVIG ever did for me. Within 2hrs i feel better, but ... you need to keep using it." Bad outcome from dimenter01: no effect at 8mg/day for months. All anecdotal, not advice.
- quote: I’ve taken it it helps with pain but it’s temporary. You have to keep doing it from time to time at least and it’s expensive. Check out sites on it for dosage duration etc. at a min do it for a 28 days at 4 mg
- claim_ids: c49
- hash: `64ae70bf9e30f04e`

### s37 · reddit · ok
- title: Possible CIDP Diagnosis- Doctor will not treat
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/1lercvh/possible_cidp_diagnosis_doctor_will_not_treat/
- summary: User with sciatica and suspected autoimmune neuropathy considering ARA-290 (anecdotal interest). Another reports no success after months at 8mg/day.
- quote: I’m considering trying ARA-290, as it not only has shown to heal nerves, but limit autoimmune issues as well.
- claim_ids: c50
- hash: `517907d162886908`

### s38 · reddit · ok
- title: some anecdote/anecdata from my recent experience with peptides
- url: https://www.reddit.com/r/Sciatica/comments/1qa6g93/some_anecdoteanecdata_from_my_recent_experience/
- summary: Comment suggests trying ARA-290 for sciatica (anecdotal, not advice); notes cost via resellers vs wholesaler.
- quote: Give ARA 290 a shot. youll want to go through a wholesaler from china as it can get quite expensive through resellers
- claim_ids: c51
- hash: `1a4eb4aaa4e5741b`

### s39 · reddit · ok
- title: Is chronic sciatica for life?
- url: https://www.reddit.com/r/Sciatica/comments/1kkb0y7/is_chronic_sciatica_for_life/
- summary: Comment recommends ARA-290 (with others) for nerve damage/sciatica (anecdotal, not advice).
- quote: Bpc 157, tb500, ghk cu and ara 290. They speed up healing of ligaments, muscles and various other systems in the body. The main ones are bpc and tb500 for healing. Ara 290 is more for nerve damage.
- claim_ids: c52
- hash: `1e3bf4ad12831ceb`

### s40 · reddit · ok
- title: Sciatica keeping me up at night
- url: https://www.reddit.com/r/Sciatica/comments/1kr81ke/sciatica_keeping_me_up_at_night/
- summary: Comment notes ARA-290 reportedly helps with sciatica (anecdotal reference, not advice).
- quote: If you are into peptides there are a few that may help. ARA-290 reportedly helps with sciatica
- claim_ids: c53
- hash: `00fd0667450c1917`

## Provenance (28 model passes)
- chain valid: yes · head: `c13bc2df92cf29ed`

- synthesize_body · grok/grok-4.3 · 2026-06-29T14:25 · hash `f90ac181489f`
- sources · grok-4.3 · 2026-06-29T17:56 · hash `e1d12e8ab16a`
- sources · grok-4.3 · 2026-06-29T17:57 · hash `c99fd360612b`
- sources · grok-4.3 · 2026-06-29T17:57 · hash `e1e690d79541`
- repair · repair · 2026-06-29T19:39 · hash `140eaae8fe23`
- claim · fill-slots · 2026-06-29T20:53 · hash `63f30e52b39b`
- claim · fill-slots · 2026-06-29T20:53 · hash `4513b7c9af21`
- voxel_divide · owner · 2026-07-17T02:38 · hash `c13bc2df92cf`

## Question graph
- questions: 0 · evidence ingests: 3

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ara-290-sciatica/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ara-290-sciatica/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ara-290-sciatica","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ara-290-sciatica|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ara-290-sciatica|tier|assertion`
- **iMessage ask:** `ara-290-sciatica|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ara-290-sciatica`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ara-290-sciatica/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ara-290-sciatica/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*